OrthoPediatrics Corp · Q4 2022 earnings

Briefing

OrthoPediatrics Corp. reported a 25% year-over-year increase in revenue for the fourth quarter of 2022, reaching $31.0 million, and a net loss of $7.8 million.

OrthoPediatrics Corp. announced its Q4 2022 financial results, with revenue increasing by 25% year-over-year to $31.0 million. The company experienced growth in both domestic and international markets, driven by its core businesses and recent acquisitions. However, the company reported a net loss of $7.8 million for the quarter.

• Q4 2022 revenue increased 25% year-over-year to $31.0 million.
• Domestic revenue increased 15% and international revenue increased 67% in Q4 2022.
• Full year 2022 revenue increased 25% year-over-year to $122.3 million.
• The company helped nearly 17,000 children in Q4 2022 and approximately 70,000 for the full year.

Headline financials

Revenue & EPS history

OrthoPediatrics expects full year 2023 revenue to be in the range of just over $146.0 million to $149.0 million, representing growth of 20% to 22% over 2022 revenue. The guidance assumes roughly $5.0 million of combined revenue contribution from MD Ortho and Pega Medical before the acquisitions become organic on their anniversaries. The Company also expects its annual set deployment to be approximately $25.0 million and expects to generate $3.0 million to $4.0 million of adjusted EBITDA for full year 2023.